These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Maribavir (ViroPharma).
    Author: Lu H, Thomas S.
    Journal: Curr Opin Investig Drugs; 2004 Aug; 5(8):898-906. PubMed ID: 15600248.
    Abstract:
    ViroPharma, under license from GlaxoSmithKline, is developing maribavir, a DNA synthesis inhibitor for the potential prevention and treatment of human cytomegalovirus infections related to transplants (including solid organ and hematopoietic stem cells), congenital transmission, and in patients with HIV infection. In July 2004, a phase II trial was initiated.
    [Abstract] [Full Text] [Related] [New Search]